Increased expression of mutant forms of p53 oncogene in primary lung cancer
- 24 March 1990
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 335 (8691), 675-679
- https://doi.org/10.1016/0140-6736(90)90801-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- Oncogene expression in small‐cell lung cancer cell lines and a testicular germ‐cell tumor: Activation of the N‐myc gene and decreased RB mRNAInternational Journal of Cancer, 1989
- The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigenCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Epidermal growth factor receptors in lung tumoursThe Journal of Pathology, 1987
- Cellular heterogeneity in lung cancerHistopathology, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979